The determination of stage in nonmuscle urothelial carcinoma: Staining pattern of caspase-8

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):192-196. doi: 10.4103/IJPM.IJPM_161_17.

Abstract

Context: Urothelial carcinoma (UC) is one of the most frequent epithelial tumors worldwide.

Aims: We aimed to investigate the protein expressions of caspase-8, p53, murine double minute 2 (mdm2), and p14ARF in nonmuscle UCs and to correlate the findings with clinicopathological characteristics.

Settings and design:: A total of 50 patients who had pTa and pT1 tumors were analyzed.

Subjects and methods: The protein expressions of caspase-8, p53, mdm2, and p14ARF were analyzed by immunohistochemistry.

Statistical analysis used: Chi-square test was done using SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA).

Results: Cytoplasmic caspase-8 expression was significantly higher in pT1 UCs while nuclear caspase-8 expression was significantly higher in pTa UCs (P = 0.005 and P = 0.011, respectively). Cytoplasmic caspase-8 expression was also higher in high-grade UCs (P = 0.035). The expression of p53, mdm2, and p14ARF was not also related with pathological stage or grade (P > 0.05 for all). The p14ARF expression was related with nuclear caspase-8 expression in most of the patients. Complete agreement among nonmuscle UCs for immunohistochemical expression of p14 and nuclear caspase-8 was seen in 41 cases, and the pairwise kappa agreement value was substantial (κ =0.614). The patients who had recurrence were positive for both p53 and mdm2 or either p53 or mdm2 (P = 0.025).

Conclusions: These results suggested that the staining pattern of caspase-8 might be helpful for determining of the stages in nonmuscle UC. It was also showed that the expression status of p53 and mdm2 were related with the recurrence.

Keywords: Caspase-8; murine double minute 2; p14 ARF; p53; urothelial carcinoma.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Caspase 8 / analysis*
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Staging / methods*
  • Neoplasms, Glandular and Epithelial / diagnosis*
  • Neoplasms, Glandular and Epithelial / pathology
  • Prognosis
  • Proto-Oncogene Proteins c-mdm2 / analysis*
  • Tumor Suppressor Protein p14ARF / analysis*
  • Tumor Suppressor Protein p53 / analysis*
  • Urothelium / pathology

Substances

  • Biomarkers, Tumor
  • TP53 protein, human
  • Tumor Suppressor Protein p14ARF
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2
  • Caspase 8